Novel anticoagulants based on inhibition of the factor VIIa/tissue factor pathway.
Johnson
K
K
Chiron Technologies, Chiron Corp., Emeryville, California 94608, USA.
Hung
D
D
D000818:Animals; D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects* / Q000502:physiology; D015942:Factor VIIa / Q000037:antagonists & inhibitors*; D006801:Humans; D051379:Mice; D011817:Rabbits; D013925:Thromboplastin / Q000187:drug effects* / Q000378:metabolism
D000925:Anticoagulants; D013925:Thromboplastin; D015942:Factor VIIa